QBE Insurance (ASX:QBE) share price on watch following UK COVID-19 court ruling

The QBE Insurance Group Ltd (ASX:QBE) share price is on watch today after an unfavourable COVID-19 court ruling in the UK…

The QBE Insurance Group Ltd (ASX: QBE) share price is not climbing higher with the market today.

In morning trade the insurance giant's shares are trading flat at $9.28 following the release of an announcement.

digital stock graph against backdrop of world map and covid bugs

Image source: Getty Images

What did QBE announce?

This morning QBE provided an update on its UK operations and the impact that a ruling by the High Court of England and Wales will have on its business.

According to the release, the High Court of England and Wales has handed down its decision in the test case commenced by the UK Financial Conduct Authority (FCA) in June 2020.

This test case was undertaken to resolve legal issues concerning the interpretation of common business interruption policy wordings.

This includes some policy wordings of QBE's UK operations, in the context of whether those policy wordings respond to COVID-19 and related government mandated nationwide lockdowns.

The company advised that the Court ruled in favour of QBE with respect to two out of three of its notifiable disease policy wordings examined and in favour of insurers with respect to denial of access policy wordings.

However, the Court ruled in favour of the insured with respect to one of QBE's notifiable disease policy wordings. This means that some of QBE policyholders are entitled to claim an insurance payout for business losses suffered when the UK went into lockdown between March and June because of COVID-19.

QBE is considering its options to appeal that decision.

What is the damage?

QBE estimates that its UK business interruption claims exposure is around $170 million before allowing for recoveries under its catastrophe reinsurance protections.

However, it believes that catastrophe reinsurance will limit the net cost of business interruption claims in its UK insurance business to $70 million. This already formed part of the $335 million net cost of COVID-19 allowed for in its recent half year results.

The company advised that it has the opportunity to apply to the Court for permission to appeal some or all of the ruling, with a decision expected to be then made in October.

And while it acknowledges that the estimated gross cost to QBE could increase or decrease, the net cost is not expected to vary.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

woman on phone
Broker Notes

With $2.4 billion in FY26 profits, are Telstra shares a good buy today?

A leading expert delivers his outlook for Telstra shares.

Read more »

Woman looking at her computer and pondering something.
Broker Notes

Barrenjoey tips this ASX financial stock to rise 73%

A new deal has impressed the analysts.

Read more »

Sell written several times on board.
Broker Notes

Sell alert! Expert calls time on Corporate Travel and CBA shares

A leading expert expects CBA and Corporate Travel shares to face significant headwinds.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Expert names Woodside and CSL shares as top buys today

A leading expert says now is the time to buy CSL and Woodside shares. But why?

Read more »

Signs of asset classes on a newspaper which says 'Where to invest your money?'.
Opinions

Where I'd invest in ASX shares after the recent RBA rate rise

These investments now look very good value to me.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Buy, hold, sell: Telix Pharmaceuticals, Qualitas, Greatland Resources shares

Here's what Mark Gardner from MPC Markets thinks of these three ASX shares.

Read more »

Two brokers analysing the share price with the woman pointing at the screen and man talking on a phone.
Broker Notes

Buy, hold, sell: Premier Investments, New Hope, Xero shares

We review three fresh buy, hold, and sell calls from expert market analysts.

Read more »

Happy businessman fist pumping while looking at a tablet.
Broker Notes

Up 120%, is it too late to buy Codan shares?

Bell Potter thinks this high-flying stock could keep rising.

Read more »